Stocktoria
Avalo Therapeutics, Inc. AVTX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2015-11-13
Avalo Therapeutics, Inc. insider transactions (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Doyle Mittie | Chief Medical Officer | 2026-06-23 | Option exercise | 1,450 | $8.04 |
| Doyle Mittie | Chief Medical Officer | 2026-06-23 | Sell | 1,450 | $18.00 |
| Riley Jennifer | Chief Strategy Officer | 2026-06-10 | Tax withheld | 588 | $13.10 |
| VARKI PAUL | Chief Legal Officer | 2026-06-10 | Tax withheld | 1,081 | $13.10 |
| Sullivan Christopher Ryan | Chief Financial Officer | 2026-06-10 | Tax withheld | 138 | $13.10 |
| Doyle Mittie | Chief Medical Officer | 2026-06-10 | Tax withheld | 1,084 | $13.10 |
Source: SEC EDGAR filings · CIK 0001534120 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.